TP53 and non-small cell lung carcinoma: Interestingly, two compounds (BPR0C123 and BPR0C259) of N-heterocyclic indolyl glyoxylamides exhibited different cytotoxicity on human NSCLC cell lines, but also induced p53-independent apoptosis and radiosensitivity to different levels [9].